← Eichor
Study identifier: NCT06124261 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Androgens and NAFLD Longitudinal Cohort Study

Condition: PCOS · NAFLD · NASH  ·  Sponsor: University of California, San Francisco

PhaseN/A
Planned participants150
Who can joinFemale, 18 Years to 42 Years
Healthy volunteersNo

About this study

The researchers want to learn how androgens, a type of sex hormone, might affect nonalcoholic fatty liver (NAFLD) in young women over time. NAFLD happens when fat builds up in the liver which can cause damage to the liver such as inflammation or scarring. Young women with a condition called polycystic ovary syndrome (PCOS) have a high risk for NAFLD, and they often have high androgen levels too. So the researchers are recruiting young women with PCOS as well as those without PCOS, and will compare changes in NAFLD over time between young women with and without PCOS. This study is funded by the National Institutes of Health

This description comes directly from the study's public registry record.

Talk to the study team

Lily C Carbullido, B.S.  ·  415-502-3725  ·  myliverhealth@ucsf.edu

Jasmine Gamez

Always discuss trial participation with your own doctor first.

Locations (2)

University of California San FranciscoSan Francisco, California, United StatesRecruiting
Duke UniversityDurham, North Carolina, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06124261